Zymeworks Inc.
The company is focused on the discovery, development and commercialization of next-generation multi-functional biopharmaceuticals with a focus on cancer treatment. It develops bispecific antibodies using its proprietary antibody and protein engineering technology platform. It has partnerships with global pharmaceutical companies, including those in Japan.
Overview
Overview | |
|---|---|
Country | Canada |
State | |
Employees | 275 |
Founded | 2003 |
Financials | |
|---|---|
Market Capitalization | 712.00M |
Revenue | 50.46M |
Operating Income | -148.57M |
Operating Margin | -294.42% |
Net Income | -125.97M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4976 / 5373 |
Sector : Healthcare | 975 / 1144 |
Industry : Biotechnology | 521 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2712 / 5565 |
Sector : Healthcare | 370 / 1182 |
Industry : Biotechnology | 159 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4893 / 5436 |
Sector : Healthcare | 952 / 1164 |
Industry : Biotechnology | 511 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3349 / 5330 |
Sector : Healthcare | 401 / 1174 |
Industry : Biotechnology | 101 / 667 |